GoAI
Get started
Green International Holdings Limited logo

Green International Holdings Limited

2700.HK

HKSEHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

HK$0.54

+HK$0.005 · +0.93%

Aug 24, 3:18 PM HKT

2700.HK company overview

Historical prices · Market data may be delayed.

Company profile

Company website

Operating within the People's Republic of China, Green International Holdings Limited delivers a variety of beauty and wellness offerings. The company's operations are segmented into its Health and Medical Business and Beauty and Wellness Business. Under its Health and Medical division, it runs hospitals and hemodialysis centers, providing specialized care in areas like internal medicine, nephrology, surgery, traditional Chinese medicine, ultrasound diagnostics, electrocardiography, medical laboratory services, and medical imaging. Additionally, the company engages in securities brokerage and asset management. Established in 2006, Green International Holdings Limited was previously known as Smart Union Group (Holdings) Limited, undergoing its name change in April 2012. Its main offices are situated in Sheung Wan, Hong Kong.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
HK
CEO
Zhoujie Yu
Listed since
Sep 29, 2006
Employees
122

Market position

52-week range

Current HK$0.54

Open
HK$0.54
Previous close
HK$0.535
Volume
20K
0.43× average
Average volume
46.53K
Average daily volume
Market cap
356.34M HKD
Beta
-0.09
Market reference 1
50-day average
HK$0.5742
-5.96% below average
200-day average
HK$0.5714
-5.49% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
323.72M HKD
EV / EBITDA
284.96×
Earnings yield
-1.07%
Free cash flow yield
-1.33%

Profitability & efficiency

Return on equity
-10.37%
Return on assets
-3.88%
Return on invested capital
-2.73%

Financial health

Current ratio
1.52×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends76%11%-54%-119%Gross margin, FY2021: 54.46%Gross margin, FY2022: 55.35%Gross margin, FY2023: 59.04%Gross margin, FY2024: 59.80%Gross margin, FY2025: 52.58%Operating margin, FY2021: -29.69%Operating margin, FY2022: -20.38%Operating margin, FY2023: -13.17%Operating margin, FY2024: -5.99%Operating margin, FY2025: -3.16%Net margin, FY2021: -102.93%Net margin, FY2022: -28.01%Net margin, FY2023: -21.76%Net margin, FY2024: -1.52%Net margin, FY2025: -7.12%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 54.46%. Gross margin FY2022 55.35%. Gross margin FY2023 59.04%. Gross margin FY2024 59.80%. Gross margin FY2025 52.58%. Operating margin FY2021 -29.69%. Operating margin FY2022 -20.38%. Operating margin FY2023 -13.17%. Operating margin FY2024 -5.99%. Operating margin FY2025 -3.16%. Net margin FY2021 -102.93%. Net margin FY2022 -28.01%. Net margin FY2023 -21.76%. Net margin FY2024 -1.52%. Net margin FY2025 -7.12%.

Income trends

Revenue

54.31M HKD+2.45%

Operating income

−1.72M HKD+46.00%

Net income

−3.87M HKD-379.06%
Income trends across reported periods83.07M HKD27.02M HKD−29.04M HKD−85.09M HKDRevenue, FY2021: 69.06M HKDRevenue, FY2022: 47.24M HKDRevenue, FY2023: 48.83M HKDRevenue, FY2024: 53.01M HKDRevenue, FY2025: 54.31M HKDOperating income, FY2021: −20.5M HKDOperating income, FY2022: −9.63M HKDOperating income, FY2023: −6.43M HKDOperating income, FY2024: −3.18M HKDOperating income, FY2025: −1.72M HKDNet income, FY2021: −71.08M HKDNet income, FY2022: −13.23M HKDNet income, FY2023: −10.63M HKDNet income, FY2024: −807K HKDNet income, FY2025: −3.87M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 69.06M HKD. Revenue FY2022 47.24M HKD. Revenue FY2023 48.83M HKD. Revenue FY2024 53.01M HKD. Revenue FY2025 54.31M HKD. Operating income FY2021 −20.5M HKD. Operating income FY2022 −9.63M HKD. Operating income FY2023 −6.43M HKD. Operating income FY2024 −3.18M HKD. Operating income FY2025 −1.72M HKD. Net income FY2021 −71.08M HKD. Net income FY2022 −13.23M HKD. Net income FY2023 −10.63M HKD. Net income FY2024 −807K HKD. Net income FY2025 −3.87M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue54.31M HKD53.01M HKD48.83M HKD47.24M HKD69.06M HKD
Cost of goods sold25.76M HKD21.31M HKD20M HKD21.09M HKD31.45M HKD
Gross profit28.55M HKD31.7M HKD28.83M HKD26.15M HKD37.61M HKD
Selling, general, and administrative30.27M HKD34.87M HKD35.26M HKD36.47M HKD58.79M HKD
Operating expenses30.27M HKD34.87M HKD35.26M HKD36.47M HKD58.11M HKD
Interest income1.18M HKD2.35M HKD2.62M HKD960K HKD155K HKD
Interest expense885K HKD1.69M HKD2.28M HKD3.33M HKD4.19M HKD
Depreciation and amortization2.85M HKD9.15M HKD9.62M HKD10.66M HKD16.79M HKD
Operating income−1.72M HKD−3.18M HKD−6.43M HKD−9.63M HKD−20.5M HKD
Net income−3.87M HKD−807K HKD−10.63M HKD−13.23M HKD−71.08M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-0

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.040.01-0.02-0.05Q2 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q3 '25Q1 '26
Q2 2022, reported Jun 30, 2022: actual -0.015, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 30, 2023: actual -0.005, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 31, 2023: actual -0.007, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 28, 2024: actual -0.009, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 30, 2024: actual -0.002, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 31, 2025: actual 0.001, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 28, 2025: actual -0.005, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 30, 2026: actual -0.001, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates29.3M26.56M23.82M21.07MQ2 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q3 '25Q1 '26
Q2 2022, reported Jun 30, 2022: actual 25.04M HKD, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 30, 2023: actual 22.2M HKD, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 31, 2023: actual 25.11M HKD, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 28, 2024: actual 23.72M HKD, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 30, 2024: actual 25.92M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 31, 2025: actual 27.09M HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 28, 2025: actual 28.18M HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 30, 2026: actual 26.13M HKD, estimate —, surprise —, Comparison unavailable.

2700.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$197.7

-3.94%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.46

-3.61%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$221.4

-2.89%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.60

-4.71%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.06

-6.11%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$99.50

-2.83%

Continue in GoAI

Research 2700.HK

research.disclaimer